| Key Financial Ratios of Aarti Pharmalabs (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
28.39 |
22.14 |
18.95 |
11.78 |
-0.18 |
|
| Diluted EPS (Rs.) |
28.38 |
22.14 |
18.95 |
11.78 |
-0.18 |
|
| Cash EPS (Rs.) |
37.12 |
29.42 |
25.10 |
31.60 |
-0.18 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
203.44 |
178.92 |
158.74 |
281.87 |
9.07 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
203.44 |
178.92 |
158.74 |
281.87 |
9.07 |
|
| Dividend / Share(Rs.) |
5.00 |
3.00 |
2.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
195.44 |
165.75 |
166.76 |
206.53 |
0.00 |
|
| PBDIT/Share (Rs.) |
48.66 |
39.41 |
34.16 |
40.01 |
-0.18 |
|
| PBIT/Share (Rs.) |
39.94 |
32.13 |
28.01 |
31.84 |
-0.18 |
|
| PBT/Share (Rs.) |
37.11 |
30.29 |
25.75 |
29.35 |
-0.18 |
|
| Net Profit/Share (Rs.) |
28.39 |
22.14 |
18.95 |
23.42 |
-0.18 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
24.89 |
23.77 |
20.48 |
19.37 |
0.00 |
|
| PBIT Margin (%) |
20.43 |
19.38 |
16.79 |
15.41 |
0.00 |
|
| PBT Margin (%) |
18.98 |
18.27 |
15.44 |
14.21 |
0.00 |
|
| Net Profit Margin (%) |
14.52 |
13.35 |
11.36 |
11.34 |
0.00 |
|
| Return on Networth / Equity (%) |
13.95 |
12.37 |
11.93 |
8.31 |
-2.02 |
|
| Return on Capital Employed (%) |
17.22 |
16.72 |
16.83 |
10.78 |
-1.87 |
|
| Return on Assets (%) |
9.44 |
8.73 |
8.74 |
5.84 |
-1.83 |
|
| Total Debt/Equity (X) |
0.21 |
0.15 |
0.14 |
0.25 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.71 |
0.71 |
0.80 |
1.03 |
0.00 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.95 |
2.04 |
2.11 |
1.85 |
54.40 |
|
| Quick Ratio (X) |
1.07 |
0.99 |
0.93 |
0.93 |
54.40 |
|
| Inventory Turnover Ratio (X) |
1.43 |
1.36 |
1.83 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
9.03 |
10.55 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
6.79 |
7.96 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
90.97 |
89.45 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
93.21 |
92.04 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
7,175.79 |
4,188.60 |
2,682.57 |
0.00 |
0.00 |
|
| EV/Net Operating Revenue (X) |
4.05 |
2.79 |
1.78 |
0.00 |
0.00 |
|
| EV/EBITDA (X) |
16.27 |
11.73 |
8.66 |
0.00 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
3.83 |
2.62 |
1.65 |
0.00 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
90.96 |
89.44 |
0.00 |
0.00 |
|
| Price/BV (X) |
3.68 |
2.43 |
1.73 |
0.00 |
0.00 |
|
| Price/Net Operating Revenue |
3.83 |
2.62 |
1.65 |
0.00 |
0.00 |
|
| Earnings Yield |
0.04 |
0.05 |
0.07 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
